Bio-Rad Officer Files Intent to Sell $214K in Company Stock
BIO-RAD LABORATORIES, INC.
Subscribe to track BIO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Bio-Rad Officer Files Intent to Sell $214K in Stock
Company: BIO-RAD LABORATORIES, INC. Form: 144 | Filed: 2025-11-06 Significance: Low
Insider: JAMES BARRY Title: Officer
Transaction: • Type: Proposed Sale • Shares: 701 • Value: $214,633 • Price (Approx): $306.18
Key Insight: An officer filed a notice of a proposed sale of common stock. The transaction is immaterial, representing less than 0.003% of the company's market capitalization.
Market Context: This is a routine filing with negligible market impact expected due to its small size relative to Bio-Rad's $8.36 billion market cap.
Comprehensive Analysis
SEC Filing Analysis: BIO-RAD LABORATORIES, INC.
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer of Bio-Rad Laboratories has filed a notice of a proposed sale of 701 shares, valued at approximately $214,633. The transaction is of low significance due to its small size.
- Market Impact: Negligible impact is expected on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | BIO-RAD LABORATORIES, INC. |
| Ticker Symbol | Not provided in filing |
| CIK | 0000012208 |
| Industry | Laboratory Analytical Instruments |
Insider Information
| Field | Value |
|---|---|
| Name | JAMES BARRY |
| CIK | 0002022345 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-06 (Approximate) |
| Transaction Code | Not Applicable |
| Security Type | Common |
| Shares Involved | 701 |
| Price Per Share | $306.18 (Approximate) |
| Total Value | $214,633.08 |
| Shares Owned After | Not specified |
| Ownership Type | Not specified |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $214,633.08 |
| % of Market Cap | 0.0026% |
| Shares Transacted | 701 |
| % of Shares Outstanding | 0.0032% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The proposed sale of $214k is a very small fraction of Bio-Rad's $8.36 billion market capitalization. Such a transaction is considered routine and does not signal any significant change in insider sentiment.
- Ownership Concentration: The number of shares being sold is negligible compared to the 22 million shares outstanding, indicating no meaningful change in ownership structure.
- Transaction Significance: The sale represents just 0.0026% of the company's market cap and 0.0032% of its shares outstanding, both of which are well below the thresholds for moderate or high significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The transaction is immaterial in both dollar value and share count relative to the company's size. It is unlikely to influence investor decisions or market sentiment.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 701 shares are a tiny fraction of typical daily trading volume.
- Sentiment Indicator: Neutral. This filing is a procedural notice of a minor sale and does not carry a bullish or bearish signal.
Additional Context
Transaction Notes
- This Form 144 filing serves as a notice of a proposed sale, indicating the insider's intent to sell the securities on or around the specified date. It is not a confirmation of a completed trade.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.